4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Recent progress on photodynamic therapy and photothermal therapy

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Noninvasive treatments for terminal cancer patients constitute a new trend in tumor treatment. Therefore, phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), has attracted considerable interest. Light and a photosensitizer (PS) are employed in both treatment methods. For PDT, the PS generates reactive oxygen species (ROS) when exposed to light, whereas for PTT, the PS generates heat. In this regard, the systematic design of new PSs has become an active area of phototherapy research in an effort to solve the problems associated with conventional PSs. In the past decade, activatable and heavy‐atom‐free PSs have become significant research areas. Therefore, we discuss our recent contributions to the PDT and PTT in this account.

          Related collections

          Most cited references87

          • Record: found
          • Abstract: not found
          • Article: not found

          Clinical development and potential of photothermal and photodynamic therapies for cancer

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy

            Despite its clinical promise, photodynamic therapy (PDT) suffers from a key drawback associated with its oxygen-dependent nature, which limits its effective use against hypoxic tumors. Moreover, both PDT-mediated oxygen consumption and microvascular damage further increase tumor hypoxia and, thus, impede therapeutic outcomes. In recent years, numerous investigations have focused on strategies for overcoming this drawback of PDT. These efforts, which are summarized in this review, have produced many innovative methods to avoid the limits of PDT associated with hypoxia.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Supramolecular photosensitizers rejuvenate photodynamic therapy

              In this review, we will cover the recent progress made in the development of supramolecular photosensitizers (PSs) for rejuvenating photodynamic therapy. Owing to its spatiotemporal selectivity and noninvasive nature, photodynamic therapy (PDT) has become a clinically promising approach for the treatment of a wide range of cancers and other diseases. However, the full potential of PDT has not been achieved thus far as a consequence of the lack of optimal photosensitizers (PSs) and/or smart transport/activation strategies. These problems, which unfortunately lie at the core of the PDT paradigm, include the oxygen reliance limits, the effect of PDT on hypoxic tumors, limitations of light penetration, and undesired skin photosensitization induced by “always on” PSs. Recently, supramolecular approaches, which rely on the use of non-covalent interactions to construct biomedical active materials, have become suitable methods for developing innovative PSs. Non-covalent interactions enable supramolecular PSs to have sensitive and controllable photoactivities, important elements needed to maximize photodynamic effects and minimize side effects. In addition, versatile supramolecular PS-assemblies can be designed so that PDT occurs synergistically with other therapeutic modalities, e.g. , photothermal therapy, leading to a potential improvement of therapeutic effectiveness. In this review, recent progress made in the development of supramolecular PSs for rejuvenating PDT will be presented. Importantly, this discussion also provides a view of future advances that will likely be made in this area and their potential clinical applications.
                Bookmark

                Author and article information

                Contributors
                Journal
                Bulletin of the Korean Chemical Society
                Bulletin Korean Chem Soc
                Wiley
                1229-5949
                1229-5949
                March 2023
                December 15 2022
                March 2023
                : 44
                : 3
                : 236-255
                Affiliations
                [1 ] Department of Chemistry and Nanoscience Ewha Womans University Seoul South Korea
                [2 ] School of Bioengineering Dalian University of Technology Dalian China
                [3 ] College of Chemistry, State Key Laboratory of Photocatalysis for Energy and the Environment, Fujian Provincial Key Laboratory for Cancer Metastasis Chemoprevention and Chemotherapy Fuzhou University Fuzhou China
                [4 ] State Key Laboratory of Organic−Inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering Beijing University of Chemical Technology Beijing P. R. China
                Article
                10.1002/bkcs.12655
                ebb347b8-0bb9-44b4-b4c8-1e46b11cdc55
                © 2023

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article